drugset / Trial / NCT02353247
Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
NaSingle-groupOpen-labelTreatment
Summary
The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.
Timeline
- Start
- 2015-08
- Primary completion
- 2017-06-29
- Completion
- 2017-06-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norethindrone | Unknown | 5 mg | Oral |
Indications
No indication recorded.